Ocala Weight Loss Program
SEMAGLUTIDE
NOW OFFERING
WEEKLY WEIGHT LOSS INJECTION PRESCRIPTION
WEIGHT LOSS
PROGRAM
$250
STARTING AT
/mo
-
REAL WEIGHT LOSS RESULTS OF UP TO 2-4 POUNDS PER WEEK
-
REDUCES APPETITE, IMPROVES CONTROL OF EATING & REDUCES FOOD CRAVINGS
-
IMPROVES INSULIN RESISTANCE, BURNS FAT AND BOOSTS ENERGY
-
SAFE AND EFFECTIVE ONCE WEEKLY INJECTION
or $70 Per Injection
Required Lab Work
on first visit, covered by insurance!
Weight Loss Program Ocala Florida | Now offering Semaglutide injections | Weekly Injections
$250 Per Month or $70 per Injection | Free Weight Loss Consultation Ocala Fl 34474
Semaglutide vs. Tirzepatide
Semaglutide is the active ingredient in Ozempic and Wegovy. It works as a GLP-1 receptor agonist to treat type 2 diabetes. People also use it to help them lose weight. Tirzepatide is the active ingredient in Mounjaro and Zepbound, which also can treat type 2 diabetes and encourage weight loss. Tirzepatide is a GLP-1 receptor agonist, too. But it also works in a second way, as what’s known as a GIP receptor agonist. GIP, short for glucose-dependent insulinotropic polypeptide, is another hormone your body makes after you eat.
So both semaglutide and tirzepatide work by acting like hormones your body normally makes after you eat. They can make your stomach empty more slowly so that you won’t want to eat again as soon. They also send signals to the brain that tell you you’re full. The main difference is that tirzepatide mimics two hormones while semaglutide mimics one.
What Is Tirzepatide?
Tirzepatide, marketed under the brand names Zepbound and Mounjaro, is prescribed to adults with type 2 diabetes and weight loss issues. As a GIP and GLP-1 receptor agonist, tirzepatide helps people lose weight by reducing hunger and slowing the passage of food from the stomach into the small intestine.
This may cause you to feel fuller for longer. Tirzepatide also lowers blood sugar levels by decreasing the amount of sugar the liver makes and increasing insulin production.
Zepbound is FDA-approved for adults who are obese or overweight and who have weight-related medical conditions like hypertension or cardiovascular disease. Zepbound should be combined with food and exercise to help you lose weight and keep it off.
Mounjaro is prescribed for people with type 2 diabetes to help lower their blood sugar levels. It should also be used in conjunction with diet and exercise.
Tirzepatide is the active ingredient of both Mounjaro and Zepbound. Both are administered subcutaneously once a week and come in single-dose pens with the same strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per 0.5 mL.
How Does Tirzepatide Work?
As a glucagon-like-peptide-1 (GLP-1) receptor agonist, tirzepatide mimics the hormone GLP-1, known to regulate hunger, causing people to eat less. It also imitates the GIP hormone (glucose-dependent insulinotropic polypeptide). This hormone is well known for raising blood glucose levels, which may lead to feelings of fullness.
Tirzepatide also slows down the rate at which food passes through the intestines, which prolongs the time that food remains in the stomach, resulting in a feeling of fullness and satisfaction.
Tirzepatide may also increase energy, leading to more frequent movement throughout the day and increased calorie burn.
What Is Semaglutide?
Semaglutide is another diabetic and weight loss drug available. Like tirzepatide, semaglutide is taken once weekly along with changing habits like diet and exercise.
Semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus. It is a GLP-1 agonist that decreases glucagon release, increases insulin release, delays stomach emptying, and suppresses appetite.
Wegovy injection is approved to help adults and children 12 years of age and older who are obese or some adults who are overweight and have weight-related medical issues lose and maintain their weight.
Ozempic is an injection prescribed to people with diabetes who have cardiovascular disease to help reduce the risk of cardiovascular events like a heart attack or stroke. Rybelsus is a tablet used to reduce blood sugar levels in people with type 2 diabetes. It is taken once a day.
How Does Semaglutide Work?
While tirzepatide targets both the GLP 1 and the GIP receptor agonist, semaglutide only mimics the GLP-1 receptor agonist, which is released by your gut after you eat to signal to the brain that you are full.
Semaglutide lowers high blood sugar by raising the amount of insulin produced, decreasing the amount of glucagon released, and prolonging stomach emptying. It also regulates appetite, reducing your cravings.
Is Tirzepatide Better Than Semaglutide?
Research suggests tirzepatide may cause a more significant reduction in body weight than semaglutide. However, additional comparative studies are needed to draw firm findings. It’s also important to remember that each person reacts to medications differently. Semaglutide may work better for some people than tirzepatide.
During a 72-week study, those receiving the maximum dose of tirzepatide lost an average of 21% of their body weight. This was compared to the placebo group, which saw a 3% loss.
Studies on the efficacy of semaglutide have also been positive. Participants who were overweight or obese and took the medication lost an average of 5.9% of their body weight after three months (13 weeks) and 10.9% after six months (26 weeks).
Tirzepatide’s more significant weight loss result may be likely because it targets both the GLP-1 receptor and the GIP receptor, while semaglutide only targets the GLP-1 receptor.
What Is the Difference Between Semaglutide and Tirzepatide?
Although both tirzepatide and semaglutide are used to assist patients with type 2 diabetes and obesity in losing weight and improving cardiovascular diseases, there are some significant distinctions between them.
The main distinctions between these drugs are that they’re two different classes of drugs and have slightly differing targets in the brain.
Tirzepatide is unique in its class of medications since it targets both the GIP and GLP-1 receptor agonists. By activating these receptors, tirzepatide functions differently from semaglutide.
Semaglutide exclusively targets the GLP-1 receptor agonist. However, it has been on the market longer than tirzepatide and is supported by greater research and clinical proof.
Weight Loss Clinic in Ocala Florida Just off state road hwy 200 SW 60 Street Ocala Florida 34474